Document is current
Any future updates will be listed below
-
Authors
Loria, Rossella
Laquintana, Valentina
Scalera, Stefano
Fraioli, Rocco
Caprara, Valentina
Falcone, Italia
Bazzichetto, Chiara
Di Martile, Marta
Rosanò, Laura
Del Bufalo, Donatella
Bossi, Gianluca
Sperduti, Isabella
Terrenato, Irene
Visca, Paolo
Soddu, Silvia
Milella, Michele
Ciliberto, Gennaro
Falcioni, Rita
Ferraresi, Virginia
Bon, Giulia https://orcid.org/0000-0002-5409-5864
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 18622)
- License Information
-
More Information
Article History
Received: 5 November 2021
Accepted: 2 April 2022
First Online: 19 April 2022
Change Date: 2 June 2022
Change Type: Update
Change Details: Funding statement has been updated to: This work was supported by grant AIRC IG 18622 (to MM and RF), and by Funds Ricera Corrente 2022 from Italian Ministry of Health.
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki.
: All of the authors are aware of and agree to the content of the paper and their being listed as a co-author of the paper.
: VF has received speaker fees/advisory boards from Novartis, Bristol Meyers Squibb, MSD and Pierre Fabre, not related to the topic of this manuscript. MM has received honoraria and consultancy fees from Novartis, not related to the topic of this manuscript. The remaining authors declare no competing financial interests.
